Advanced therapies feature in new Innovative Medicines Initiative Calls for proposals, along with topics on artificial intelligence; the need for reliable, relevant health information; and ways of incorporating patients’ perspectives into healthcare and cancer clinical trials.
In medical image analysis, AI can surpass human experts; in diabetes it can raise an alarm in time to head off a glycaemic event. Hints of its power, but concerns about privacy are slowing deployment of AI tools
IMI has involved patients in its projects and activities since the beginning. Now, IMI is creating a pool of patient experts to strengthen the role and voice of patients in IMI activities at strategic and operational levels.
At a Science|Business event in Norway, students, technology experts and teachers debated the merits of new breeds of healthcare delivery. There are benefits, but digital health must be thoughtfully controlled and users properly trained
Vaccines are an effective public health measure, yet public distrust in immunisation is resulting in outbreaks of preventable diseases. IMI’s ADVANCE project worked to create an open system for monitoring vaccine coverage, benefits and risks in Europe.
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.